Could cord blood transfusions protect fragile preemies?
NCT ID NCT07636473
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using cord blood, rich in fetal hemoglobin, for transfusions in preterm infants can reduce serious complications like blindness, lung disease, and gut problems. Researchers will compare outcomes in 200 very low birth weight babies who receive either cord blood or standard adult donor blood. The goal is to see if the special properties of cord blood help prevent damage caused by oxygen stress.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cord blood red blood cell transfusion
- What this could lead to
- If successful, this could offer a safer transfusion option for preterm infants, potentially reducing serious complications like blindness and lung disease.
- What could go wrong
- This is an early-stage trial with 200 participants, so results may not be conclusive. The intervention is complex and may not show clear benefits over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less be more? testing transfusion limits in ECMO
- A simple blood test trend may flag ICU patients at risk
- Rethinking anemia: does blood hemoglobin tell the whole story?
- A simple nutrient may shield Babies' brains from iron deficiency
- School health rooms and trained teachers: a new hope for Zambia's children?
- Can a pill replace EPO shots for anemia in kidney disease?